


Illumina’s Market Struggles Deepen as U.S.-China Tensions Escalate
Illumina, a prominent biotech firm specializing in gene-sequencing technology, is

Pharma Giant Eli Lilly to Buy Biotech Firm Morphic for $3.2 Billion
Eli Lilly and Company, a global leader in pharmaceutical development,

Alumis IPO Priced at $16, Targets $210M Funding
Alumis, a clinical-stage immunology biotech company, has priced its downsized

Diamond Biofund Becomes First Biotech VC Firm Listed on Taiwan Stock Exchange
Introduction: Diamond Biofund has recently achieved a groundbreaking milestone by
